Victory Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.8K | Sell |
|
|||||
|
2025
Q2 | $20.1K | Buy |
|
|||||
|
2025
Q1 | $23.7K | Sell |
|
|||||
|
2024
Q4 | $37.6K | Buy |
|
|||||
|
2024
Q3 | $48.7K | Sell |
|
|||||
|
2024
Q2 | $41.2K | Buy |
|
|||||
|
2024
Q1 | $61.1K | Sell |
|
|||||
|
2023
Q4 | $45.8K | Buy |
|
|||||
|
2023
Q3 | $36.8K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $166K | Buy |
|
|||||
|
2022
Q1 | $120K | Buy |
|
|||||
|
2021
Q4 | $189K | Sell |
|
|||||
|
2021
Q3 | $334K | Sell |
|
|||||
|
2021
Q2 | $1.57M | Sell |
|
|||||
|
2021
Q1 | $33.5M | Sell |
|
|||||
|
2020
Q4 | $25.6M | Sell |
|
|||||
|
2020
Q3 | $45.7M | Buy |
|
|||||
|
2020
Q2 | $45.8M | Buy |
|
|||||
|
2020
Q1 | $396K | Buy |
|
|||||
|
2019
Q4 | $321K | Buy |
|
|||||
|
2019
Q3 | $239K | Buy |
|